Bharat Immunologicals & Biologicals Corporation Ltd.
Snapshot View

26.40 +0.35 ▲1.3%

07 October 2022, 12:44:00 PM
Volume: 4,897

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bibcol.com
Market Cap 114.00 Cr.
Enterprise Value(EV) 177.36 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -2.03 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.07 Trailing Twelve Months Ending 2022-03
Book Value / Share -2.64 Trailing Twelve Months Ending 2022-03
Price to Book Value -10.01 Calculated using Price: 26.40
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 4.32 Cr. 43,180,000 Shares
FaceValue 10
Company Profile
The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.34%
1 Week
+2.52%
1 Month
-19.14%
3 Month
-7.04%
6 Month
-25.63%
1 Year
-52.22%
2 Year
+4.76%
5 Year
+12.58%
10 Year
+62.96%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 3.81 -16.25 16.94 -10.76 -17.00 -39.93 -158.64
Return on Capital Employed (%) 42.29 9.07 -8.52 31.11 -17.52 -10.70 -21.87 -73.05 -8.08
Return on Assets (%) 7.28 1.81 -8.50 10.80 -8.51 -7.22 -8.97 -18.41 -6.35

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 42 40 41 35 42 38 31 20 34 105
Non Curr. Liab. -2 3 4 1 -1 -5 -4 -8 -14 -15
Curr. Liab. 45 48 35 30 14 13 88 101 64 101
Minority Int.
Equity & Liab. 85 91 80 66 55 45 115 113 84 192
Non Curr. Assets 8 7 7 6 8 7 16 20 50 126
Curr. Assets 77 84 74 60 47 38 99 93 34 65
Misc. Exp. not W/O
Total Assets 85 91 80 66 55 45 115 113 84 192

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 203 146 128 124 35 84 67 85 78 67
Other Income 6 1 1 1 1 4 1 2 1 1
Total Income 209 147 129 125 36 88 68 87 79 68
Total Expenditure -191 -143 -132 -111 -43 -93 -77 -106 -83 -73
PBIDT 18 4 -3 14 -7 -5 -9 -19 -4 -6
Interest -6 -1 -6 -4 -1 -2 -5 -5 -6 -6
Depreciation -1 -1 -1 -1 0 0 0 0 0 0
Taxation -5 -1 3 -3 4 2 4 6 1 -2
Exceptional Items
PAT 6 2 -6 7 -4 -6 -10 -18 -9 -13
Adjusted EPS 1 0 -1 2 -1 -1 -2 -4 -2 -3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 31 -12 8 -9 -17 3 -32 34 12 -42
Cash Fr. Inv. 0 0 0 1 1 1 1 1 1 1
Cash Fr. Finan. 0 -6 -1 -2 -3 -3 31 -34 -12 45
Net Change 31 -18 7 -10 -20 1 -1 1 0 3
Cash & Cash Eqvt 41 23 30 20 0 1 0 1 1 5

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25
Public 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 06 Oct 2022
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 17Th October 2022
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2022 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 17th October 2022 to approve the financial results of the Company for the quarter ended 30th September 2022.
Thu, 29 Sep 2022
Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI LODR 2015 For The Year 2021-22.
In pursuance of compliance of Regulation 7(3) of SEBIs LODR 2015 with Stock Exchange please find attached herewith a certificate duly signed by Mas Services Limited RTA and the Company Secretary of the company for the year ended 31.03.2022 please.
Fri, 23 Sep 2022
Reg. 34 (1) Annual Report.
The Annual General Meeting of the Shareholder of the company is scheduled on 30.09.2022 and the Annual Report to be placed at Shareholders meeting for consideration is submitted at BSE please.

Technical Scans View Details >>

Thu, 06 Oct 2022
High Delivery Percentage High Delivery Percentage
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Decrease 1 Month High Decrease 1 Month
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 959.45 +0.6%
Divi's Laboratories Ltd. 99,171.10 3,734.00 +0.0%
Cipla Ltd. 91,534.16 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,596.45 -0.5%
Zydus Lifesciences Ltd. 42,831.42 424.75 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 424.75 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 424.75 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 424.75 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.75 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 424.75 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 424.75 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 959.45 +0.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,734.00 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,138.65 +0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,396.40 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,387.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,596.45 -0.5%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 424.75 +0.4%

FAQ's On Bharat Immunologicals & Biologicals Corporation Ltd.

What is Bharat Immunological share price?

Can I buy Bharat Immunological shares now?

What is the Market Cap of Bharat Immunological?

What is the 52 Week High and Low of Bharat Immunological?

What is the trend of Bharat Immunological share price?